Executives

Pharma

Astellas CEO resists 'rescue BD' as Xtandi patent cliff nears

With Xtandi set to lose U.S. patent protection next year, Astellas’ CEO fielded questions this week about his company’s BD strategy ahead of the loss.

Angus Liu Jan 15, 2026 10:42am

Bristol Myers CEO pledges to 'cast a broad net' in dealmaking

Jan 12, 2026 4:28pm

Viking, Aspen enlist commercial chiefs to prep for launches

Jan 7, 2026 11:18am

Imre hires Nadine Lafond from Ogilvy Health to fill CEO vacancy

Dec 9, 2025 9:30am

Emma Walmsley upholds £40B sales target in final GSK CEO report

Oct 29, 2025 11:14am

Halozyme CEO targets new deals as IRA uncertainty subsides

Oct 14, 2025 9:40am